Access Campaign
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug
MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
Secrets Cost Lives: Transparency and access to medical products
Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health
Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines
MSF reveals cost of its landmark TB clinical trial: €34 million
As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination
Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests
